Cargando…

Survey of Pathogen-Lowering and Immuno-Modulatory Effects Upon Treatment of Campylobacter coli-Infected Secondary Abiotic IL-10(−/−) Mice with the Probiotic Formulation Aviguard(®)

The prevalence of infections with the zoonotic enteritis pathogen Campylobacter coli is increasing. Probiotic formulations constitute promising antibiotic-independent approaches to reduce intestinal pathogen loads and modulate pathogen-induced immune responses in the infected human host, resulting i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weschka, Dennis, Mousavi, Soraya, Biesemeier, Nina, Bereswill, Stefan, Heimesaat, Markus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224786/ https://www.ncbi.nlm.nih.gov/pubmed/34070972 http://dx.doi.org/10.3390/microorganisms9061127

Ejemplares similares

Treatment with the Probiotic Product Aviguard(®) Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Microbiota composition and inflammatory immune responses upon peroral application of the commercial competitive exclusion product Aviguard(®) to microbiota-depleted wildtype mice
por: HEIMESAAT, MARKUS M., et al.
Publicado: (2020)

Inflammatory Immune Responses and Gut Microbiota Changes Following Campylobacter coli Infection of IL-10(-/-) Mice with Chronic Colitis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2021)

Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation in Campylobacter coli-Infected Secondary Abiotic IL-10(−/−) Mice
por: Kløve, Sigri, et al.
Publicado: (2020)

Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2021)

The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10(−/−) Mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Toll-Like Receptor-4 Dependent Intestinal and Systemic Sequelae Following Peroral Campylobacter coli Infection of IL10 Deficient Mice Harboring a Human Gut Microbiota
por: Kløve, Sigri, et al.
Publicado: (2020)

Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model
por: Bereswill, Stefan, et al.
Publicado: (2022)

The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
por: GENGER, CLAUDIA, et al.
Publicado: (2020)

Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis
por: Bereswill, Stefan, et al.
Publicado: (2021)

Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Disease alleviating effects following prophylactic lemon and coriander essential oil treatment in mice with acute campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2023)

Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2023)

Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute Campylobacter jejuni-induced Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Immune responses upon Campylobacter jejuni infection of secondary abiotic mice lacking nucleotide-oligomerization-domain-2
por: Bereswill, Stefan, et al.
Publicado: (2017)

Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection
por: Helmy, Yosra A., et al.
Publicado: (2020)

Protease Activity of Campylobacter jejuni HtrA Modulates Distinct Intestinal and Systemic Immune Responses in Infected Secondary Abiotic IL-10 Deficient Mice
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Campylobacter jejuni infection induces acute enterocolitis in IL-10(-/-) mice pretreated with ampicillin plus sulbactam
por: Heimesaat, Markus M., et al.
Publicado: (2022)

Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2020)

Peroral Clove Essential Oil Treatment Ameliorates Acute Campylobacteriosis—Results from a Preclinical Murine Intervention Study
por: Bereswill, Stefan, et al.
Publicado: (2021)

Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Murine fecal microbiota transplantation lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses in Campylobacter jejuni infected secondary abiotic mice
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice
por: Du, Ke, et al.
Publicado: (2022)

Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

Absence of Nucleotide-Oligomerization-Domain-2 Is Associated with Less Distinct Disease in Campylobacter jejuni Infected Secondary Abiotic IL-10 Deficient Mice
por: Heimesaat, Markus M., et al.
Publicado: (2017)

Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Vitamin D in Acute Campylobacteriosis–Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model
por: Mousavi, Soraya, et al.
Publicado: (2019)

Molecular Targets in Campylobacter Infections
por: Heimesaat, Markus M., et al.
Publicado: (2023)

Small Intestinal Pro-Inflammatory Immune Responses Following Campylobacter Jejuni Infection of Secondary Abiotic IL-10(–/–) Mice Lacking Nucleotide-Oligomerization-Domain-2
por: Heimesaat, Markus M., et al.
Publicado: (2017)

Immunomodulatory and Antimicrobial Effects of Vitamin C
por: Mousavi, Soraya, et al.
Publicado: (2019)

Human microbiota associated IL-10(−/−) mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
por: Shayya, Nizar W., et al.
Publicado: (2023)

Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2020)

A literature survey on antimicrobial and immune-modulatory effects of butyrate revealing non-antibiotic approaches to tackle bacterial infections
por: DU, KE, et al.
Publicado: (2021)

Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni
por: Lobo de Sá, Fábia D., et al.
Publicado: (2021)

Antibacterial properties of capsaicin and its derivatives and their potential to fight antibiotic resistance – A literature survey
por: FÜCHTBAUER, SAMUEL, et al.
Publicado: (2021)

Vitamin E as promising adjunct treatment option in the combat of infectious diseases caused by bacterial including multi-drug resistant pathogens – Results from a comprehensive literature survey
por: HARTMANN, MINNJA S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_52tmlpn50538g4h1u2qo72jadh